Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management.
about
Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic reviewUbc9 expression predicts chemoresistance in breast cancer.Brentuximab vedotin in hodgkin lymphoma and anaplastic large cell lymphomaPeripheral neuropathy caused by Paclitaxel and docetaxel: an evaluation and comparison of symptomsChemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor.Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors.Ixabepilone development across the breast cancer continuum: a paradigm shift.Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer.Adjuvant Systemic Therapy of Breast Cancer.Clinical experience with nanoparticle albumin-bound paclitaxel, a novel taxane anticancer agent, and management of adverse events in females with breast cancerEribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer.Brentuximab vedotin in transplant-naive patients with relapsed or refractory hodgkin lymphoma: analysis of two phase I studies.Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphomaBiodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer modelsNeuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancerAnimal models of chemotherapy-evoked painful peripheral neuropathiesPersistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project.The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.Are macrophages in tumors good targets for novel therapeutic approaches?
P2860
Q28270819-ED860258-E499-429D-9DEA-CC740CDA5F86Q33579371-83AA48D7-7A25-4CB8-8D16-8608D5D7756EQ33885565-9D13E27F-B78C-49B2-9CE0-4E169C02284FQ33886036-E596B7DA-EF5A-471C-8033-FC302829CD85Q33984071-997ADEC6-E0FC-4558-B3B4-8B39872F567EQ34111215-34671B07-C86F-4D1B-B4FC-35D27BB4481FQ34257256-CC4B22FF-98C8-4435-845B-963587B8F115Q34417996-E9C52186-64A0-4860-8E2E-675B554C57FFQ34458581-0FB75917-97C8-4546-BCEC-FA196CC3FEC1Q35095595-F5B66E74-F295-4F48-85EF-4584D2C0063DQ35167769-EFB365F1-4C5D-439D-BAE1-CA52EA78D984Q35599745-90F1EFE3-C419-42A4-B28D-D9765A6A7A80Q36182830-D3859E0A-F801-44C7-90AC-275F8EF80F16Q36822162-6A233E56-3542-4A24-856B-F74D1B8A97BBQ37013417-5371C761-4FF8-4AB1-8ED0-1AA913F592BFQ37065942-DCC7E76E-53D2-421B-BB1A-608C366BD5D6Q37605341-EC6F2939-A6D3-4477-BEA1-E13FB8E32427Q38693665-1C64E276-9EA1-407B-9EDE-171B09571B39Q52565567-2CB65AE5-3860-4248-ACE2-022B0F549E18Q53665718-650FCF20-D4E9-4445-BCB1-E63757A252F9
P2860
Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management.
@en
Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management.
@nl
type
label
Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management.
@en
Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management.
@nl
prefLabel
Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management.
@en
Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management.
@nl
P1476
Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management.
@en
P2093
Joseph C Arezzo
Sandra M Swain
P304
P577
2008-06-01T00:00:00Z